Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Are the Current Preclinical Models Adequate to Evaluate CAR-T Cell Therapy in Paediatric High-Grade Gliomas?

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Dual tumour-myeloid targeting of glioblastoma with GPNMB CAR-T cells.

Nature·2026
Same author

Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell function.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

TP63 expression correlates with mesenchymal-like gene signature in patient-derived recurrent glioblastoma cells.

Biochemical and biophysical research communications·2026
Same author

uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target.

Science translational medicine·2026
Same author

Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for Glioblastoma.

International journal of cancer·2026

相关实验视频

Updated: Sep 18, 2025

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

13.3K

脑瘤干细胞:新的视角

Alisha Anand1, Chitra Venugopal2, Sheila K Singh3,4

  • 1Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.

Methods in molecular biology (Clifton, N.J.)
|June 24, 2025
PubMed
概括

大脑瘤干细胞 (BTSC) 驱动大脑癌症的进展和治疗耐药性. 使用单细胞测序,CRISPR和AI的创新研究旨在克服这些挑战,以获得更好的诊断和治疗.

关键词:
人工智能的人工智能脑瘤干细胞 脑瘤干细胞在CRISPR-Cas9系统中,细胞表面制造器 细胞表面制造器光激活细胞分类 分类.内异质性 内异质性机器学习 机器学习单细胞RNA测序的一个细胞.护理的标准 护理的标准瘤微环境是一个微环境.

更多相关视频

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

18.3K
Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
09:36

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

10.4K

相关实验视频

Last Updated: Sep 18, 2025

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

13.3K
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

18.3K
Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
09:36

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

10.4K

科学领域:

  • 在瘤学瘤学.
  • 神经科学是一个神经科学.
  • 癌症干细胞生物学

背景情况:

  • 由于其复杂性和侵略性,脑癌存在重大挑战,往往导致患者预后不佳.
  • 脑瘤干细胞 (BTSC) 是脑瘤转变,进展和治疗抵抗的关键驱动因素.
  • BTSC具有神经干细胞 (NSC) 的特征,包括自我更新和分化,以及异常信号和代谢途径.

研究的目的:

  • 审查脑瘤干细胞 (BTSC) 研究当前的挑战,重点关注导致治疗耐药性和复发的因素.
  • 探索创新技术和前性研究策略,以克服BTSC介导治疗失败.
  • 要突出先进工具的潜力,如单细胞RNA测序,CRISPR查和人工智能在脑癌研究.

主要方法:

  • 使用光激活细胞分类 (FAC) 进行基于细胞表面标记的BTSC隔离和丰富.
  • 采用单细胞RNA测序来捕获单个细胞水平的详细遗传和转录组信息.
  • 利用CRISPR技术进行查,以确定潜在的治疗漏洞,并应用AI/机器学习来发现新目标.

主要成果:

  • BTSC及其利基领域对治疗耐药性和脑癌中瘤复发有显著的贡献.
  • 单细胞RNA测序为BTSC异质性提供了前所未有的遗传和转录基因洞察力.
  • 克里斯普尔和人工智能/机器学习方法在识别新的治疗点和提高诊断准确度方面显示出前景.

结论:

  • 解决BTSC及其微环境的复杂性对于改善脑癌治疗结果至关重要.
  • 像单细胞测序,CRISPR和AI这样的先进技术对于未来的脑瘤学研究和开发至关重要.
  • 在了解和准BTSC方面不断的创新是克服治疗耐药性和提高脑癌患者存活率的关键.